News | September 26, 2012

New IMV Survey Shows Aging of Installed MR Scanners in the U.S.

Average age of installed MRI scanners in U.S. has increased, according to new market research report by IMV

IMV Medical Information Division MRI Systems Clinical Trial

September 26, 2012 — The average age of installed magnetic resonance imaging (MRI) scanners in the United States has increased from eight years in 2007 to 10.9 years in 2011, according to a new market research report by IMV Medical Information Division.

“The last spike of new MR installations extended from 2002 to 2004,” observed Lorna Young, senior director, market research at IMV. “The research finds that the MRI market is ready for replacement of the older units that are at the end of their useful lives. Providers are also planning to take advantage of the wider bore sizes that are now available."

Survey results indicate that two out of every three new MR installations will be wide-bore. Young noted that 1.5T units are still the mainstay of the modality, representing 70 percent of all recently installed MR scanners and 70 percent of all systems currently in place.

While overall procedures performed in the United States rose an estimated 6 percent to 32 million procedures from 2010 to 2011, utilization at the site level increased 4 percent and the average number of MR procedures performed per scanner fell 4 percent. Respondents reported that reductions in reimbursements, from both Medicare and third-party payors, caused their MR revenues to decline despite the slight increase in utilization.

Lower and upper extremity procedures grew 15 percent from 2010 to 2011, making these applications the biggest contributor to MR procedure growth, the research found. Other areas of MR procedure growth were orthopedic and neurological procedures.   

The risk of nephrogenic system fibrosis (NSF) remains a concern for providers considering the use of gadolinium-based contrast agents (GBCA). More than 75 percent of the survey respondents stated that NSF prevention is a priority patient-management issue for their departments.

The report describes trends in MR patient exams by procedure type, MR installed base by manufacturer and year of installation, planned purchases and market scenarios for unit sales through 2016, contrast media expenditures by supplier, site operations characteristics, and department managers' opinions about the factors affecting the future outlook for MR at their facility. Other report highlights include:

  • 63 percent of all MR studies were performed in hospitals or in hospital-owned imaging centers.
  • 22 percent of all MR users plan on purchasing a new system in the next three years.
  • 6 percent of all MR sites use a mobile service.
  • 37 percent of all MR procedures used contrast in 2011, declining from 42 percent in 2010.
  • Spine, brain, and lower and upper extremities comprised the four largest categories of MR procedures.


For more information: www.MReport.imvinfo.com


Related Content

News | Cardiovascular Clinical Studies

April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...

Home April 30, 2024
Home
News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
Subscribe Now